Technical Analysis for TLPH - Talphera, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| 20 DMA Resistance | Bearish | 2.13% | |
| Doji - Bullish? | Reversal | 2.13% | |
| Gapped Down | Weakness | 2.13% | |
| 20 DMA Resistance | Bearish | -1.73% | |
| NR7 | Range Contraction | -1.73% | |
| Narrow Range Bar | Range Contraction | -1.73% | |
| Outside Day | Range Expansion | -0.76% | |
| NR7 | Range Contraction | -0.76% | |
| NR7-2 | Range Contraction | -0.76% | |
| Narrow Range Bar | Range Contraction | -0.76% |
| Alert | Time |
|---|---|
| Up 2% | about 1 hour ago |
| Up 1% | about 1 hour ago |
| 10 DMA Resistance | about 23 hours ago |
| Fell Below 10 DMA | about 23 hours ago |
| 5x Volume Pace | 1 day ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/08/2024
Talphera, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. Talphera's lead product candidate, Niyad™ is a lyophilized formulation of nafamostat and is currently being studied under an investigational device exemption, or IDE, as an anticoagulant for the extracorporeal circuit, and has received Breakthrough Device Designation status from the FDA. Talphera is also developing two pre-filled syringes in-licensed from its partner Aguettant: Fedsyra™, a pre-filled ephedrine syringe, and PFS-02, a pre-filled phenylephrine syringe. This release is intended for investors only
Sector: Healthcare
Industry: Medical Devices
Keywords: Pharmaceutical Medication Medical Equipment FDA Syringe Drug Paraphernalia Innovative Therapies Phenylephrine Investigational Device Exemption
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Pharmaceutical Medication Medical Equipment FDA Syringe Drug Paraphernalia Innovative Therapies Phenylephrine Investigational Device Exemption
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 1.61 |
| 52 Week Low | 0.425 |
| Average Volume | 68,911 |
| 200-Day Moving Average | 0.89 |
| 50-Day Moving Average | 1.11 |
| 20-Day Moving Average | 1.03 |
| 10-Day Moving Average | 1.02 |
| Average True Range | 0.08 |
| RSI (14) | 44.75 |
| ADX | 15.09 |
| +DI | 15.34 |
| -DI | 19.91 |
| Chandelier Exit (Long, 3 ATRs) | 0.99 |
| Chandelier Exit (Short, 3 ATRs) | 1.17 |
| Upper Bollinger Bands | 1.16 |
| Lower Bollinger Band | 0.90 |
| Percent B (%b) | 0.34 |
| BandWidth | 25.24 |
| MACD Line | -0.02 |
| MACD Signal Line | -0.03 |
| MACD Histogram | 0.0024 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.08 | ||||
| Resistance 3 (R3) | 1.09 | 1.07 | 1.07 | ||
| Resistance 2 (R2) | 1.07 | 1.05 | 1.07 | 1.06 | |
| Resistance 1 (R1) | 1.03 | 1.03 | 1.05 | 1.02 | 1.06 |
| Pivot Point | 1.01 | 1.01 | 1.02 | 1.01 | 1.01 |
| Support 1 (S1) | 0.97 | 0.99 | 0.99 | 0.96 | 0.93 |
| Support 2 (S2) | 0.95 | 0.97 | 0.95 | 0.92 | |
| Support 3 (S3) | 0.91 | 0.95 | 0.92 | ||
| Support 4 (S4) | 0.90 |
